Vycor Medical (VYCO) Non-Current Assets (2010 - 2026)
Vycor Medical's (VYCO) quarterly Non-Current Assets came in at $177297.0 in Q2 2026, down 45.38% year-over-year from $324591.0 in Q2 2025, and down 12.67% quarter-over-quarter from $203024.0 in Q1 2026.
Analysis
Vycor Medical (VYCO) Non-Current Assets (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Non-Current Assets for 17 consecutive years, with $177297.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 45.38% year-over-year to $177297.0 in Q2 2026; TTM through Jun 2026 was $925918.0, a 32.63% decrease from a year earlier, with the FY2025 full-year figure at $266998.0, down 29.46% from the prior year.
- Non-Current Assets was $177297.0 for Q2 2026 at Vycor Medical, down from $203024.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $428581.0 in Q3 2023 and troughed at $177297.0 in Q2 2026.
- A 5-year average of $333491.7 and a median of $341275.5 in 2022 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets rose 23.13% in 2024 and slumped 45.38% in 2026, its largest moves.
- Over 5 years, Non-Current Assets stood at $342415.0 in 2022, then advanced by 19.21% to $408208.0 in 2023, then dropped by 7.28% to $378503.0 in 2024, then dropped by 29.46% to $266998.0 in 2025, then slumped by 33.6% to $177297.0 in 2026.
- The last three Non-Current Assets figures came in at $177297.0 (Q2 2026), $203024.0 (Q1 2026), and $266998.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | 177,297.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177,297.00 |
| Mar 31, 2026 | 203,024.00 |
| Dec 31, 2025 | 266,998.00 |
| Sep 30, 2025 | 278,599.00 |
| Jun 30, 2025 | 324,591.00 |
| Mar 31, 2025 | 340,136.00 |
| Dec 31, 2024 | 378,503.00 |
| Sep 30, 2024 | 331,174.00 |
| Jun 30, 2024 | 353,478.00 |
| Mar 31, 2024 | 380,612.00 |
| Dec 31, 2023 | 408,208.00 |
| Sep 30, 2023 | 428,581.00 |
| Jun 30, 2023 | 287,070.00 |
| Mar 31, 2023 | 314,662.00 |
| Dec 31, 2022 | 342,415.00 |
| Sep 30, 2022 | 370,022.00 |
| Jun 30, 2022 | 397,386.00 |
| Mar 31, 2022 | 420,095.00 |
| Dec 31, 2021 | 447,953.00 |
| Sep 30, 2021 | 477,402.00 |